Keros Therapeutics Inc (KROS)
53.85
-0.29
(-0.54%)
USD |
NASDAQ |
Nov 21, 16:00
53.85
0.00 (0.00%)
After-Hours: 20:00
Keros Therapeutics Price to Book Value: 4.094 for Nov. 21, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 20, 2024 | 4.116 |
| November 19, 2024 | 4.076 |
| November 18, 2024 | 4.106 |
| November 15, 2024 | 4.304 |
| November 14, 2024 | 4.588 |
| November 13, 2024 | 4.795 |
| November 12, 2024 | 4.932 |
| November 11, 2024 | 5.181 |
| November 08, 2024 | 5.163 |
| November 07, 2024 | 5.106 |
| November 06, 2024 | 5.052 |
| November 05, 2024 | 4.758 |
| November 04, 2024 | 4.558 |
| November 01, 2024 | 4.557 |
| October 31, 2024 | 4.412 |
| October 30, 2024 | 4.394 |
| October 29, 2024 | 4.431 |
| October 28, 2024 | 4.474 |
| October 25, 2024 | 4.477 |
| October 24, 2024 | 4.388 |
| October 23, 2024 | 4.273 |
| October 22, 2024 | 4.371 |
| October 21, 2024 | 4.443 |
| October 18, 2024 | 4.513 |
| October 17, 2024 | 4.501 |
| Date | Value |
|---|---|
| October 16, 2024 | 4.581 |
| October 15, 2024 | 4.449 |
| October 14, 2024 | 4.458 |
| October 11, 2024 | 4.404 |
| October 10, 2024 | 4.258 |
| October 09, 2024 | 4.271 |
| October 08, 2024 | 4.396 |
| October 07, 2024 | 4.430 |
| October 04, 2024 | 4.487 |
| October 03, 2024 | 4.413 |
| October 02, 2024 | 4.517 |
| October 01, 2024 | 4.405 |
| September 30, 2024 | 4.278 |
| September 27, 2024 | 5.032 |
| September 26, 2024 | 5.070 |
| September 25, 2024 | 5.032 |
| September 24, 2024 | 4.956 |
| September 23, 2024 | 4.862 |
| September 20, 2024 | 4.974 |
| September 19, 2024 | 5.110 |
| September 18, 2024 | 4.966 |
| September 17, 2024 | 4.906 |
| September 16, 2024 | 4.958 |
| September 13, 2024 | 5.079 |
| September 12, 2024 | 5.028 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
2.721
Minimum
Oct 25 2023
14.67
Maximum
Dec 17 2020
4.995
Average
4.651
Median
Price to Book Value Benchmarks
| Eli Lilly and Co | 49.99 |
| Regeneron Pharmaceuticals Inc | 2.790 |
| Scholar Rock Holding Corp | 31.55 |
| NovaBay Pharmaceuticals Inc | 3.291 |
| Palatin Technologies Inc | -- |
Price to Book Value Related Metrics
| PS Ratio | 2885.10 |
| PEG Ratio | -1.968 |
| Price | 53.85 |
| Earnings Yield | -9.68% |
| Market Cap | 2.181B |
| PEGY Ratio | -1.968 |